Back to Journals » OncoTargets and Therapy » Volume 14
Study Protocol
Study on Efficacy and Safety of Low-Dose Apatinib Combined with Camrelizumab and SOX Regimen as First-Line Treatment of Locally Advanced and Unresectable Gastric/Gastroesophageal Junction Cancer: A Protocol for an Open-Label, Dose Escalation and Extension Phase Ib Clinical Trial
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,085 | Dovepress* | 3,597+ | 373 | 3,970 | |
PubMed Central* | 488 | 188 | 676 | ||
Totals | 4,085 | 561 | 4,646 | ||
*Since 21 September 2021 |
View citations on PubMed Central and Google Scholar